Crunching the numbers for LXRX... Refresh in a moment for the full analysis.
LEXICON PHARMACEUTICALS, INC. (LXRX)
Healthcare
mixed
$1.72
Updated: 2026-04-12
47
TradeApes Score
hold
Financial Strength
55
Mixed
Operating Trend
65
Healthy
Valuation
40
Weak
Capital Allocation
20
Stressed
Risk
35
Weak
Key Findings
+
Net cash position — more cash on hand than total debt
−
Significant dilution — share count up more than 5% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.